Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Ivan Fan-Ngai Hung, Kwok-Yung Yuen, Ruiqi Zhang et al.|The Lancet|2020

Cited by 1.6k